As a student of science, you have many career opportunities beyond working in the ivory tower which you may not have even considered. Learn about alternative careers in science in this post by Sheeva Azma and Nidhi Parekh.
Category Archives: Sheeva Azma
How to Communicate Effectively as A Scientist on Social Media
Learn about how to communicate science effectively on social media sites such as Twitter in this article by Fancy Comma, LLC’s Sheeva Azma, a scientist and science writer.
Latest Research Suggests COVID-19 Affects the Brain, Raises Even More Questions
Scientists have identified some of COVID-19’s harmful effects on the brain. In this post, Sheeva Azma of Fancy Comma, LLC and Nidhi Parekh of The Shared Microscope unpack the latest research on COVID-19’s neurological effects.
How Does Functional Neuroimaging Work?
Fancy Comma, LLC’s Sheeva Azma discusses everything you need to know about noninvasive functional brain imaging such as functional Magnetic Resonance Imaging (fMRI), electroencephalography (EEG), and magnetoencephalography (MEG).
Elon Musk’s Neuralink — A Sci-Fi Dream or the Next Big Thing in Brain Implants?
In this post, Fancy Comma, LLC’s Sheeva Azma recaps Elon Musk’s recent Neuralink livestream event held on August 28, 2020.
Can We Make “Good” Journalism “Great”?
In this article, Fancy Comma, LLC’s Sheeva Azma talks about the importance of journalism and ways to make good journalism “great.”
How to Navigate COVID-19 as a Freelancer
Learn how to adapt business strategy during uncertain times such as the COVID-19 pandemic
How I Learned to Love Neuroplasticity — And Why You Should, Too
In this post, Fancy Comma, LLC’s Sheeva Azma talks about what neuroplasticity is and how it helps humans be more adaptable.
In the COVID-19 Pandemic, Science Reporting Matters
In this post, Fancy Comma, LLC’s Sheeva Azma reflects on the state of biomedical science journalism in the COVID-19 pandemic.
How Does Moderna’s mRNA Vaccine for COVID-19 Work?
In this post, learn about how the Moderna COVID-19 vaccine works. and why this mRNA-based vaccine is a front-runner in the race to a COVID-19 vaccine to mitigate the ongoing novel coronavirus pandemic.
Fancy Comma, LLC 